BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22046792)

  • 1. [Borderline ovarian tumors and global radiation in relation with climate change impact].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial ovarian tumors in adolescents: a retrospective pathologic study and a critical review of the literature.
    Grapsa D; Kairi-Vassilatou E; Kleanthis C; Dastamani C; Fillipidou A; Kondi-Pafiti A
    J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):386-8. PubMed ID: 21945630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of borderline ovarian tumors.
    Tîrnovanu MC; Amancei S; Dumitrescu A; Onofriescu M; Dumitraşcu I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1069-75. PubMed ID: 23700890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric borderline ovarian tumors: a retrospective analysis.
    Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    J Pediatr Surg; 2010 Oct; 45(10):1955-60. PubMed ID: 20920712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery in advanced borderline tumors.
    Viganò R; Petrone M; Pella F; Rabaiotti E; De Marzi P; Mangili G
    Fertil Steril; 2010 Aug; 94(3):1163-5. PubMed ID: 20036359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of borderline ovarian tumors].
    Leng JH; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1993 Aug; 28(8):498-501. PubMed ID: 8293694
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.
    Cruz-Galarza D; Pérez-Rodríguez O; Laboy-Torres J; Gutiérrez-Rivera S
    Bol Asoc Med P R; 2014; 106(1):54-6. PubMed ID: 24791367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
    Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
    Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
    Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
    Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brenner tumor of the ovary--a clinicopathological report of 5 cases].
    Li AY; Li XL; Xing LY
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):218-220, 10. PubMed ID: 3447865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.